NKE Stock UPDATES Nike Inc (NKE) 92.97 11/02/2014 23:13:32

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nike Inc (NKE) 92.97 $NKE

Is It Time to Invest in Brazil?
Jay Jenkins, The Motley Fool - Motley Fool - Sat Nov 01, 1:43PM CDT
Last Sunday, over 115 million Brazilians cast their ballots and re-elected President Dhilma Rousseff to another four-year term leading the emerging country's government. Voting is compulsory in the Brazilian political system, which explains the...
GFA: 2.14 (+0.09), PBR: 11.70 (+0.38), NKE: 92.97 (-0.03), EWZ: 43.24 (+0.49)

41 Billionaires: Meet the Richest Person in Every U.S. State
at The Street - Sat Nov 01, 9:11AM CDT
No matter where you live, there's someone living nearby who is richer than you are -- unless you're on this new list out from Wealth-X.
CLR: 56.37 (+1.25), CCL: 40.15 (+0.08), NKE: 92.97 (-0.03), GMCR: 151.75 (+1.77), WMT: 76.27 (-0.18), LVS: 62.26 (+0.76), ORCL: 39.05 (+0.55), DISH: 63.65 (+1.36), HUN: 24.40 (+0.43), HCA: 70.05 (+0.65), LB: 72.12 (-0.01), BRK.B: 140.16 (+0.62), MSFT: 46.95 (+0.90)

21.5% Return Seen to Date on SmarTrend NIKE Call (NKE)
Comtex SmarTrend(R) - Fri Oct 31, 4:38PM CDT
SmarTrend identified an Uptrend for NIKE (NYSE:NKE) on May 27th, 2014 at $76.54. In approximately 5 months, NIKE has returned 21.47% as of today's recent price of $92.97.
NKE: 92.97 (-0.03)

IBD 50 Stock Nike Scores With Fit Crowd And Investors
at Investor's Business Daily - Fri Oct 31, 3:26PM CDT
Nahin Monsoor just can't seem to have enough Nike basketball shoes. The 12-year-old New York City native already owns four pairs of Nike (NKE) basketball shoes and was eying several more at the Foot Locker (FL) store on Manhattan's Upper East Side on...
KO: 41.88 (+0.48), UA: 65.58 (+1.35), NKE: 92.97 (-0.03), SKX: 54.75 (-0.41), MCD: 93.73 (+0.35), FL: 56.01 (+0.16), AAPL: 108.00 (+1.02), LULU: 41.65 (-0.03)

NIKE Rises 1.14% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Oct 30, 4:16PM CDT
NIKE (NYSE:NKE) traded in a range yesterday that spanned from a low of $91.55 to a high of $93.00. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $92.54 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NKE: 92.97 (-0.03)

Watch for NIKE to Potentially Pullback After Gaining 1.14% Yesterday
Comtex SmarTrend(R) - Thu Oct 30, 4:15PM CDT
NIKE (NYSE:NKE) traded in a range yesterday that spanned from a low of $91.55 to a high of $93.00. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $92.54 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NKE: 92.97 (-0.03)

5 Things Under Armour, Inc.'s Management Wants You to Know
Steve Symington, The Motley Fool - Motley Fool - Wed Oct 29, 3:15PM CDT
When Under Armour announced third-quarter results last Thursday, the market wasn't quite sure what to think. After all, the bears reasoned, Under Armour stock sported a lofty valuation trading at more than 75 times trailing earnings, and 55 times...
UA: 65.58 (+1.35), NKE: 92.97 (-0.03)

Iconix Beats on Q3 Earnings & Revenues; Raises EPS View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 12:50PM CDT
Iconix Brand Group, Inc. (ICON) reported upbeat third quarter 2014 results, wherein both earnings and sales exceeded the Zacks Consensus Estimate. This clothing brand licensing company also raised its earnings guidance for fiscal 2014.
ICON: 40.01 (+0.01), NKE: 92.97 (-0.03), SKX: 54.75 (-0.41), DECK: 87.46 (-0.33)

Ralph Lauren Cuts Sales Outlook, Beats On Q2 Profit
at Investor's Business Daily - Wed Oct 29, 11:06AM CDT
Double-digit international growth boosted Ralph Lauren's (RL) earnings, but the apparel maker's second-quarter revenue still disappointed Wall Street. And expectations for third-quarter revenue have already been lowered as the company cut its fiscal...
UA: 65.58 (+1.35), NKE: 92.97 (-0.03), KORS: 78.59 (+0.69), RL: 164.84 (-1.27)

DICK'S Sporting Expansion Update: 6 Stores in the Offing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:33PM CDT
DICK'S Sporting Goods Inc.'s (DKS) store expansion continues unabated. The company announced opening of 6 new stores on Nov 7 with celebrations of the launch continuing over the weekend.
DSW: 29.65 (-0.45), UA: 65.58 (+1.35), NKE: 92.97 (-0.03), DKS: 45.37 (+0.46)

Now Is Not the Time to Buy Lululemon Athletica -- Here's Why
Andrew Marder, The Motley Fool - Motley Fool - Tue Oct 28, 8:00AM CDT
Last year, lululemon athletica went from the top of the charts to the bottom of the barrel. By the end of the year, it was looking as if the company could do no right. Then, at the beginning of 2014, Lululemon brought in a new CEO, changed things...
UA: 65.58 (+1.35), NKE: 92.97 (-0.03), LULU: 41.65 (-0.03)

3 Reasons You Shouldn't Invest in the World's Fastest-Growing Economy
Justin Loiseau, The Motley Fool - Motley Fool - Tue Oct 28, 6:00AM CDT
Ghana Stock Exchange. Source: Dieu-Donne Gameli via Wikimedia Commons.  The International Monetary Fund just released its latest World Economic Outlook report . Given another cut to global economic growth projections, you might be tempted to pour...
NKE: 92.97 (-0.03), ICE: 208.29 (+4.56)

'Fast Money' Recap: Is It Still Worth Investing in Twitter?
at The Street - Tue Oct 28, 4:00AM CDT
The trading panel discussed Twitter's earnings and what to watch for Tuesday with Facebook and Buffalo Wild Wings.
TSLA: 241.70 (+3.04), GPRO: 77.10 (+8.85), MU: 33.09 (+1.27), NKE: 92.97 (-0.03), FB: 74.99 (+0.88), HAL: 55.14 (+1.22), XOM: 96.71 (+2.26), AMGN: 162.18 (+0.60), M: 57.82 (-0.08), CLF: 11.23 (+0.73), BWLD: 149.28 (-0.76), MTW: 20.84 (+0.99), SLB: 98.66 (+1.04), TWTR: 41.47 (-0.33), WEN: 8.02 (+0.01), BHI: 52.96 (+0.90)

The Single Most Important Thing Under Armour Inc. Investors Should Consider
Brian Nichols, The Motley Fool - Motley Fool - Mon Oct 27, 6:00PM CDT
For those considering an investment in Under Armour , you must realize one thing: Its stock price and growth rate aren't aligned. While that doesn't mean Under Armour is a bad company, proof that its stock is too expensive can be summed up in one...
UA: 65.58 (+1.35), NKE: 92.97 (-0.03), SKX: 54.75 (-0.41)

Can U.S. Stocks Go Higher if Oil Prices Keep Going Lower?
at The Street - Mon Oct 27, 1:56PM CDT
The "Fast Money" trading panel discussed the impact of falling oil prices on the stock market.
FDX: 167.40 (+2.11), BX: 30.12 (+0.36), NKE: 92.97 (-0.03), XBI: 171.39 (-1.98), GRMN: 55.48 (+1.34), PCL: 41.01 (+0.38), UPS: 104.91 (+1.62), TCBI: 61.15 (+0.40), UA: 65.58 (+1.35), SPY: 201.66 (+2.28), QQQ: 101.40 (+1.38), MPC: 90.90 (+0.25), SRPT: 16.17 (+0.44), MRK: 57.94 (+0.63), DIA: 173.45 (+1.85), STI: 39.14 (+0.56), CFG: 23.62 (+0.18), TEVA: 56.47 (unch), FL: 56.01 (+0.16), AAPL: 108.00 (+1.02), XLE: 87.42 (+1.74)

Buffalo Wild Wings Investors Get Some Good News for a Change
Rich Duprey, The Motley Fool - Motley Fool - Mon Oct 27, 8:00AM CDT
The beer-and-wings joint will be able to kick off the new year with a new corporate sponsorship deal. Photo: Flickr via Mike Mozart. Wings and sports chain Buffalo Wild Wings  recently confirmed it was sponsoring the Citrus Bowl on New Year's...
KO: 41.88 (+0.48), NKE: 92.97 (-0.03), ARCO: 6.16 (+0.10), MCD: 93.73 (+0.35), BWLD: 149.28 (-0.76)

18.7% Return Seen to Date on SmarTrend NIKE Call (NKE)
Comtex SmarTrend(R) - Fri Oct 24, 10:59AM CDT
SmarTrend identified an Uptrend for NIKE (NYSE:NKE) on May 27th, 2014 at $76.54. In approximately 5 months, NIKE has returned 18.65% as of today's recent price of $90.81.
NKE: 92.97 (-0.03)

Skechers Falls Despite Solid Q3 Earnings & Revenue Increases - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 9:09AM CDT
Skechers USA Inc. (SKX) continued its superb financial run in the third quarter of 2014 but investors' were disappointed by a sizable negative impact from foreign exchange fluctuations to the earnings per share.
BWS: 26.59 (-1.03), NKE: 92.97 (-0.03), SKX: 54.75 (-0.41), DECK: 87.46 (-0.33)

Under Armour (UA) Crushes Earnings; Stock Stumbles Anyway - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Thu Oct 23, 5:29PM CDT
Despite a solid earnings beat, Under Armour (UA) shares failed to rise in Thursday trading.
UA: 65.58 (+1.35), NKE: 92.97 (-0.03)

Are Blue-Chip Stocks Past Their Prime or Still Worth Owning?
at The Street - Thu Oct 23, 3:15PM CDT
The 'Fast Money' trading panel looks at which blue-chip stocks investors should own, as well as at the overall stock market.
MMM: 153.77 (+1.67), GE: 25.81 (+0.14), HON: 96.12 (+0.53), NKE: 92.97 (-0.03), PRU: 88.54 (+1.05), UTX: 107.00 (+0.66), XBI: 171.39 (-1.98), SKX: 54.75 (-0.41), IBB: 296.62 (-0.08), KKR: 21.56 (+0.13), INTC: 34.01 (+1.43), UPS: 104.91 (+1.62), SPY: 201.66 (+2.28), IBM: 164.40 (+0.05), DIA: 173.45 (+1.85), DAN: 20.46 (+0.36), CAT: 101.41 (+1.25), MSFT: 46.95 (+0.90), KO: 41.88 (+0.48), IR: 62.62 (+0.89), DIS: 91.38 (+1.16), CLF: 11.23 (+0.73), WLT: 2.41 (+0.12), UA: 65.58 (+1.35), FTNT: 26.05 (+0.31)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Fire Congress 2026 Champions Global Fire Safety

Updated Category News Views 1

Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 1

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 1

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
Mobile Iron IV Expansions: Targeting Texas Health Needs

Updated Category News Views 13

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 6

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Updated Category News Views 7

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 2

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading

Top 5 Most Recently Viewed Articles

ADC Therapeutics Welcomes New Talent with Employee Grants

Updated Category News Views 101

ADC Therapeutics Expands Team with New Inducement Grant ADC Therapeutics SA (NYSE: ADCT), a leader in the field of antibody drug conjugates (ADCs), recently made headlines by offering a grant of options to acquire 6,000 of the company's common shares to a newly hired employee. This strategic move highlights the company's commitment to attracting top talent essential for...

Continue Reading
Allegro MicroSystems Welcomes New VP of Global Sales Vision

Updated Category News Views 322

Allegro MicroSystems Appoints a New Leader Allegro MicroSystems, Inc. (NASDAQ: ALGM), a prominent name in the field of power and sensing semiconductor solutions, has recently announced an exciting change within their executive team. Rick Madormo has been appointed as the Senior Vice President of Worldwide Sales. This strategic move is designed to further enhance Allegro's...

Continue Reading
Exciting New Water Park to Enhance Westgate River Ranch

Updated Category News Views 883

Westgate River Ranch Resort & Rodeo Announces New Water Park Westgate River Ranch Resort & Rodeo has kicked off the construction of its highly anticipated River Country Water Park, bringing an exciting water attraction to visitors. This new project is aimed at enhancing the already popular resort and providing a unique experience for guests. A Thrilling Addition for...

Continue Reading
Fulgent Genetics to Report Q3 2024 Financial Results Soon

Updated Category News Views 34

Fulgent Genetics Announces Upcoming Q3 2024 Financial Results Fulgent Genetics, Inc. (NASDAQ: FLGT) is gearing up to share its financial performance for the third quarter of 2024. The results are expected to be released before the markets open on a key upcoming Friday. Details of the Financial Announcement Fulgent is committed to transparency in its financial operations....

Continue Reading
Oppenheimer Signals Optimism for Incyte's Future Growth Potential

Updated Category News Views 178

Exciting Developments for Incyte Corporation Recently, Oppenheimer reiterated its Outperform rating along with a price target of $81.00 for Incyte Corporation (NASDAQ:INCY), a prominent player in the biopharmaceutical industry. The analysts at Oppenheimer have noted key developments that are expected to significantly influence Incyte's stock trajectory. Shifting Focus...

Continue Reading